Movement Disorders Clinical Trials

Find Movement Disorders Clinical Trials Near You

Development of Digital Diagnostics and Intervention Services for Parkinson's Disease

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In this project, ocular motor, pupil and gait data in people with Parkinson's disease (PD) will be collected in order to develop machine learning models for the diagnosis and monitoring of PD. With this, the investigators aim to advance the state of the art in PD diagnosis and monitoring. By integrating the principles of machine learning with high-quality sensor data, more accurate and earlier diagnosis could potentially be achieved. Ocular motor and pupil data will be collected with the standard clinical examination and with neos, a medical device approved for objective ocular motor and pupil measurement. Gait will be collected using an IMU sensor and GaitQ senti, a consumer device that allows for an objective and continuous remote gait monitoring.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Diagnosis of idiopathic Parkinson's disease (UK Brain Bank Criteria) or other appropriate condition specific scale \[stroke, multiple sclerosis, arthritis or osteoporosis\]

• Able to self-report history of daily gait freezing and/or festination for people with PD or gait and/or transfers affected by condition

• Able to walk unsupported or using an aid for at least 5 minutes and satisfactory completion of the Canadian PARQ and if over 69 used to carrying out this level of exercise

• Adult (+18 years old)

• Normal or corrected-to-normal vision (Snellen Visual Acuity \> 12/18) or safe to mobilise with support

• Montreal Cognitive assessment score \>21 or ability to follow 2 stage commands

⁃ Healthy participants \[Phase 1,2,3\]

• With no long-term conditions affecting movement

• Able to walk unsupported or using an aid for at least 3 minutes and satisfactory completion of the Canadian PARQ and if over 69 used to carrying out this level of exercise

• Adult (+18 years old)

• Normal or corrected-to-normal vision (Snellen Visual Acuity \> 12/18) or safe to mobilise with support

• Montreal Cognitive assessment score \>21 or ability to follow 2 stage commands

Locations
Other Locations
United Kingdom
University of Exeter
RECRUITING
Exeter
Contact Information
Primary
Pavlos Evangelidis, PhD
p.evangelidis@exeter.ac.uk
00447866138722
Backup
Helen Dawes, PhD
H.Dawes@exeter.ac.uk
01392 40 2969
Time Frame
Start Date: 2024-12-20
Estimated Completion Date: 2026-04-01
Participants
Target number of participants: 80
Treatments
Experimental: Feasibility of using the MachineMD and gaitQ devices
To complete gaitQ and MachineMD digital feasibility assessment and intervention service development
Related Therapeutic Areas
Sponsors
Collaborators: machineMD AG, GaitQ company, University of Zurich, University Hospital, Zürich
Leads: University of Exeter

This content was sourced from clinicaltrials.gov